Human Phenotype Ontology 
Grandparent Node:
expand
Abnormal ovarian morphology (HP:0031065)help
Parent Node:
expand
Ovarian cyst (HP:0000138)help
..Starting node
..expand
Polycystic ovaries (HP:0000147)help
Term ID: 147
Name: Polycystic ovaries
Synonym: Polycystic ovary; Polycystic ovary disease; Sclerocystic ovaries
Definition:
Comments:
Reference: HP:0000147
Genes and Diseases:
 
       Child Nodes:
........expandEnlarged polycystic ovaries (HP:0008675) help

 Sister Nodes: 
..expandCalcified ovarian cyst (HP:0030425) help
..expandHemorrhagic ovarian cyst (HP:0012886) help
..expandOvarian dermoid cyst (HP:0025274) help
..expandOvarian serous cystadenoma (HP:0012887) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0000147HP:0000147Polycystic ovaries0AGPAT2 CL E G H10555325ORPHA:528Congenital generalized lipodystrophyHP:0040284 - Very rare85
HP:0000147HP:0000147Polycystic ovaries0AGPAT2 CL E G H10555325OMIM:608594Lipodystrophy, congenital generalized, type 1.85
HP:0000147HP:0000147Polycystic ovaries0AKT1 CL E G H207391ORPHA:201Cowden syndrome54
HP:0000147HP:0000147Polycystic ovaries0AKT1 CL E G H207391ORPHA:744Proteus syndrome54
HP:0000147HP:0000147Polycystic ovaries0AKT2 CL E G H208392ORPHA:79085AKT2-related familial partial lipodystrophyHP:0040282 - Frequent12
HP:0000147HP:0000147Polycystic ovaries0ALMS1 CL E G H7840428ORPHA:64Alström syndromeHP:0040283 - Occasional404
HP:0000147HP:0000147Polycystic ovaries0ANTXR2 CL E G H11842921732ORPHA:2176Infantile systemic hyalinosisHP:0040281 - Very frequent49
HP:0000147HP:0000147Polycystic ovaries0ATM CL E G H472795ORPHA:100Ataxia-telangiectasiaHP:0040281 - Very frequent3267
HP:0000147HP:0000147Polycystic ovaries0BAZ1B CL E G H9031961ORPHA:904Williams syndromeHP:0040283 - Occasional
HP:0000147HP:0000147Polycystic ovaries0BCL7B CL E G H92751005ORPHA:904Williams syndromeHP:0040283 - Occasional
HP:0000147HP:0000147Polycystic ovaries0BSCL2 CL E G H2658015832ORPHA:528Congenital generalized lipodystrophyHP:0040284 - Very rare105
HP:0000147HP:0000147Polycystic ovaries0BSCL2 CL E G H2658015832OMIM:269700Lipodystrophy, congenital generalized, type 2.105
HP:0000147HP:0000147Polycystic ovaries0BUD23 CL E G H11404916405ORPHA:904Williams syndromeHP:0040283 - Occasional
HP:0000147HP:0000147Polycystic ovaries0CAV1 CL E G H8571527ORPHA:528Congenital generalized lipodystrophyHP:0040284 - Very rare11
HP:0000147HP:0000147Polycystic ovaries0CAVIN1 CL E G H2841199688ORPHA:528Congenital generalized lipodystrophyHP:0040284 - Very rare48
HP:0000147HP:0000147Polycystic ovaries0CBX2 CL E G H847331552ORPHA:24246,XY complete gonadal dysgenesisHP:0040281 - Very frequent3
HP:0000147HP:0000147Polycystic ovaries0CIDEC CL E G H6392424229ORPHA:435651CIDEC-related familial partial lipodystrophyHP:0040281 - Very frequent8
HP:0000147HP:0000147Polycystic ovaries0CLIP2 CL E G H74612586ORPHA:904Williams syndromeHP:0040283 - Occasional
HP:0000147HP:0000147Polycystic ovaries0CORIN CL E G H1069919012ORPHA:275555PreeclampsiaHP:0040284 - Very rare5
HP:0000147HP:0000147Polycystic ovaries0CYB5A CL E G H15282570ORPHA:9079646,XY disorder of sex development due to isolated 17,20-lyase deficiencyHP:0040281 - Very frequent2
HP:0000147HP:0000147Polycystic ovaries0CYP11B1 CL E G H15842591ORPHA:90795Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiencyHP:0040283 - Occasional112
HP:0000147HP:0000147Polycystic ovaries0CYP17A1 CL E G H15862593ORPHA:9079646,XY disorder of sex development due to isolated 17,20-lyase deficiencyHP:0040281 - Very frequent53
HP:0000147HP:0000147Polycystic ovaries0CYP19A1 CL E G H15882594ORPHA:91Aromatase deficiency60
HP:0000147HP:0000147Polycystic ovaries0CYTB CL E G H45197427ORPHA:137675Histiocytoid cardiomyopathyHP:0040284 - Very rare
HP:0000147HP:0000147Polycystic ovaries0DHH CL E G H508462865ORPHA:24246,XY complete gonadal dysgenesisHP:0040281 - Very frequent21
HP:0000147HP:0000147Polycystic ovaries0DHX37 CL E G H5764717210ORPHA:24246,XY complete gonadal dysgenesisHP:0040281 - Very frequent2
HP:0000147HP:0000147Polycystic ovaries0DMRT1 CL E G H17612934ORPHA:24246,XY complete gonadal dysgenesisHP:0040281 - Very frequent2
HP:0000147HP:0000147Polycystic ovaries0DNAJC30 CL E G H8427716410ORPHA:904Williams syndromeHP:0040283 - Occasional
HP:0000147HP:0000147Polycystic ovaries0EIF4H CL E G H745812741ORPHA:904Williams syndromeHP:0040283 - Occasional
HP:0000147HP:0000147Polycystic ovaries0ELN CL E G H20063327ORPHA:904Williams syndromeHP:0040283 - Occasional172
HP:0000147HP:0000147Polycystic ovaries0ESR1 CL E G H20993467ORPHA:785Estrogen resistance syndrome13
HP:0000147HP:0000147Polycystic ovaries0FKBP6 CL E G H84683722ORPHA:904Williams syndromeHP:0040283 - Occasional
HP:0000147HP:0000147Polycystic ovaries0FLT1 CL E G H23213763ORPHA:275555PreeclampsiaHP:0040284 - Very rare11
HP:0000147HP:0000147Polycystic ovaries0FOS CL E G H23533796ORPHA:528Congenital generalized lipodystrophyHP:0040284 - Very rare
HP:0000147HP:0000147Polycystic ovaries0FOXL2 CL E G H6681092ORPHA:572333Blepharophimosis-ptosis-epicanthus inversus syndrome plusHP:0040283 - Occasional92
HP:0000147HP:0000147Polycystic ovaries0FSHR CL E G H24923969ORPHA:64739Ovarian hyperstimulation syndrome50
HP:0000147HP:0000147Polycystic ovaries0GTF2I CL E G H29694659ORPHA:904Williams syndromeHP:0040283 - Occasional1
HP:0000147HP:0000147Polycystic ovaries0GTF2IRD1 CL E G H95694661ORPHA:904Williams syndromeHP:0040283 - Occasional1
HP:0000147HP:0000147Polycystic ovaries0GTF2IRD2 CL E G H8416330775ORPHA:904Williams syndromeHP:0040283 - Occasional1
HP:0000147HP:0000147Polycystic ovaries0HNF1A CL E G H692711621OMIM:142330Hepatic adenomas, familial.161
HP:0000147HP:0000147Polycystic ovaries0KLLN CL E G H10014474837212ORPHA:201Cowden syndrome1
HP:0000147HP:0000147Polycystic ovaries0LIMK1 CL E G H39846613ORPHA:904Williams syndromeHP:0040283 - Occasional
HP:0000147HP:0000147Polycystic ovaries0LIPE CL E G H39916621ORPHA:435660LIPE-related familial partial lipodystrophyHP:0040281 - Very frequent7
HP:0000147HP:0000147Polycystic ovaries0LMNA CL E G H40006636ORPHA:280365Autosomal semi-dominant severe lipodystrophic laminopathyHP:0040282 - Frequent645
HP:0000147HP:0000147Polycystic ovaries0LMNA CL E G H40006636ORPHA:2229Dilated cardiomyopathy-hypergonadotropic hypogonadism syndromeHP:0040281 - Very frequent645
HP:0000147HP:0000147Polycystic ovaries0LMNA CL E G H40006636ORPHA:2348Familial partial lipodystrophy, Dunnigan typeHP:0040283 - Occasional645
HP:0000147HP:0000147Polycystic ovaries0LMNA CL E G H40006636ORPHA:79084Familial partial lipodystrophy, Köbberling typeHP:0040282 - Frequent645
HP:0000147HP:0000147Polycystic ovaries0LMNA CL E G H40006636OMIM:151660Lipodystrophy, familial partial, type 2.645
HP:0000147HP:0000147Polycystic ovaries0LMNB2 CL E G H848236638OMIM:608709Lipodystrophy, partial, acquired, susceptibility to.11
HP:0000147HP:0000147Polycystic ovaries0MAP3K1 CL E G H42146848ORPHA:24246,XY complete gonadal dysgenesisHP:0040281 - Very frequent13
HP:0000147HP:0000147Polycystic ovaries0METTL27 CL E G H15536819068ORPHA:904Williams syndromeHP:0040283 - Occasional1
HP:0000147HP:0000147Polycystic ovaries0MLXIPL CL E G H5108512744ORPHA:904Williams syndromeHP:0040283 - Occasional1
HP:0000147HP:0000147Polycystic ovaries0MMP14 CL E G H43237160ORPHA:371428Multicentric osteolysis-nodulosis-arthropathy spectrumHP:0040283 - Occasional2
HP:0000147HP:0000147Polycystic ovaries0MMP2 CL E G H43137166ORPHA:371428Multicentric osteolysis-nodulosis-arthropathy spectrumHP:0040283 - Occasional64
HP:0000147HP:0000147Polycystic ovaries0MSX1 CL E G H44877391ORPHA:2228Hypodontia-dysplasia of nails syndromeHP:0040283 - Occasional12
HP:0000147HP:0000147Polycystic ovaries0NCF1 CL E G H6533617660ORPHA:904Williams syndromeHP:0040283 - Occasional13
HP:0000147HP:0000147Polycystic ovaries0NR0B1 CL E G H1907960ORPHA:39346,XX testicular disorder of sex developmentHP:0040281 - Very frequent48
HP:0000147HP:0000147Polycystic ovaries0NR0B1 CL E G H1907960ORPHA:24246,XY complete gonadal dysgenesisHP:0040281 - Very frequent48
HP:0000147HP:0000147Polycystic ovaries0NR5A1 CL E G H25167983ORPHA:213846,XX ovotesticular disorder of sex developmentHP:0040281 - Very frequent38
HP:0000147HP:0000147Polycystic ovaries0NR5A1 CL E G H25167983ORPHA:39346,XX testicular disorder of sex developmentHP:0040281 - Very frequent38
HP:0000147HP:0000147Polycystic ovaries0NR5A1 CL E G H25167983ORPHA:24246,XY complete gonadal dysgenesisHP:0040281 - Very frequent38
HP:0000147HP:0000147Polycystic ovaries0PHKA2 CL E G H52568926ORPHA:264580Glycogen storage disease due to liver phosphorylase kinase deficiencyHP:0040283 - Occasional54
HP:0000147HP:0000147Polycystic ovaries0PHKB CL E G H52578927ORPHA:79240Glycogen storage disease due to liver and muscle phosphorylase kinase deficiency101
HP:0000147HP:0000147Polycystic ovaries0PHKG2 CL E G H52618931ORPHA:264580Glycogen storage disease due to liver phosphorylase kinase deficiencyHP:0040283 - Occasional48
HP:0000147HP:0000147Polycystic ovaries0PIK3CA CL E G H52908975ORPHA:201Cowden syndrome162
HP:0000147HP:0000147Polycystic ovaries0PLIN1 CL E G H53469076ORPHA:280356PLIN1-related familial partial lipodystrophyHP:0040282 - Frequent19
HP:0000147HP:0000147Polycystic ovaries0POR CL E G H54479208OMIM:201750Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis.76
HP:0000147HP:0000147Polycystic ovaries0POR CL E G H54479208ORPHA:95699Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiencyHP:0040282 - Frequent76
HP:0000147HP:0000147Polycystic ovaries0PPARG CL E G H54689236ORPHA:528Congenital generalized lipodystrophyHP:0040284 - Very rare42
HP:0000147HP:0000147Polycystic ovaries0PPARG CL E G H54689236OMIM:604367Lipodystrophy, familial partial, type 3HP:0040283 - Occasional42
HP:0000147HP:0000147Polycystic ovaries0PPARG CL E G H54689236ORPHA:79083PPARG-related familial partial lipodystrophyHP:0040283 - Occasional42
HP:0000147HP:0000147Polycystic ovaries0PTEN CL E G H57289588ORPHA:201Cowden syndrome948
HP:0000147HP:0000147Polycystic ovaries0PTEN CL E G H57289588ORPHA:744Proteus syndrome948
HP:0000147HP:0000147Polycystic ovaries0PTEN CL E G H57289588ORPHA:2969Proteus-like syndromeHP:0040283 - Occasional948
HP:0000147HP:0000147Polycystic ovaries0RFC2 CL E G H59829970ORPHA:904Williams syndromeHP:0040283 - Occasional
HP:0000147HP:0000147Polycystic ovaries0SDHB CL E G H639010681ORPHA:201Cowden syndrome237
HP:0000147HP:0000147Polycystic ovaries0SDHC CL E G H639110682ORPHA:201Cowden syndrome147
HP:0000147HP:0000147Polycystic ovaries0SDHD CL E G H639210683ORPHA:201Cowden syndrome129
HP:0000147HP:0000147Polycystic ovaries0SEC23B CL E G H1048310702ORPHA:201Cowden syndrome60
HP:0000147HP:0000147Polycystic ovaries0SETD2 CL E G H2907218420OMIM:616831Luscan-Lumish syndrome60
HP:0000147HP:0000147Polycystic ovaries0SLC37A4 CL E G H25424061ORPHA:79259Glycogen storage disease due to glucose-6-phosphatase deficiency type IbHP:0040282 - Frequent110
HP:0000147HP:0000147Polycystic ovaries0SOX3 CL E G H665811199ORPHA:39346,XX testicular disorder of sex developmentHP:0040281 - Very frequent24
HP:0000147HP:0000147Polycystic ovaries0SOX9 CL E G H666211204ORPHA:213846,XX ovotesticular disorder of sex developmentHP:0040281 - Very frequent109
HP:0000147HP:0000147Polycystic ovaries0SOX9 CL E G H666211204ORPHA:39346,XX testicular disorder of sex developmentHP:0040281 - Very frequent109
HP:0000147HP:0000147Polycystic ovaries0SOX9 CL E G H666211204ORPHA:24246,XY complete gonadal dysgenesisHP:0040281 - Very frequent109
HP:0000147HP:0000147Polycystic ovaries0SRY CL E G H673611311ORPHA:213846,XX ovotesticular disorder of sex developmentHP:0040281 - Very frequent23
HP:0000147HP:0000147Polycystic ovaries0SRY CL E G H673611311ORPHA:39346,XX testicular disorder of sex developmentHP:0040281 - Very frequent23
HP:0000147HP:0000147Polycystic ovaries0SRY CL E G H673611311ORPHA:24246,XY complete gonadal dysgenesisHP:0040281 - Very frequent23
HP:0000147HP:0000147Polycystic ovaries0STK11 CL E G H679411389ORPHA:2869Peutz-Jeghers syndrome740
HP:0000147HP:0000147Polycystic ovaries0STOX1 CL E G H21973623508ORPHA:275555PreeclampsiaHP:0040284 - Very rare2
HP:0000147HP:0000147Polycystic ovaries0STX1A CL E G H680411433ORPHA:904Williams syndromeHP:0040283 - Occasional
HP:0000147HP:0000147Polycystic ovaries0TBL2 CL E G H2660811586ORPHA:904Williams syndromeHP:0040283 - Occasional
HP:0000147HP:0000147Polycystic ovaries0TMEM270 CL E G H13588623018ORPHA:904Williams syndromeHP:0040283 - Occasional
HP:0000147HP:0000147Polycystic ovaries0USF3 CL E G H20571730494ORPHA:201Cowden syndrome1
HP:0000147HP:0000147Polycystic ovaries0VPS37D CL E G H15538218287ORPHA:904Williams syndromeHP:0040283 - Occasional
HP:0000147HP:0000147Polycystic ovaries0WT1 CL E G H749012796ORPHA:24246,XY complete gonadal dysgenesisHP:0040281 - Very frequent177
HP:0000147HP:0008675Enlarged polycystic ovaries1AKT1 CL E G H207391ORPHA:201Cowden syndromeHP:0040283 - Occasional54
HP:0000147HP:0008675Enlarged polycystic ovaries1AKT1 CL E G H207391ORPHA:744Proteus syndromeHP:0040283 - Occasional54
HP:0000147HP:0008675Enlarged polycystic ovaries1CYB5A CL E G H15282570ORPHA:9079646,XY disorder of sex development due to isolated 17,20-lyase deficiencyHP:0040281 - Very frequent2
HP:0000147HP:0008675Enlarged polycystic ovaries1CYP17A1 CL E G H15862593ORPHA:9079646,XY disorder of sex development due to isolated 17,20-lyase deficiencyHP:0040281 - Very frequent53
HP:0000147HP:0008675Enlarged polycystic ovaries1CYP19A1 CL E G H15882594ORPHA:91Aromatase deficiencyHP:0040281 - Very frequent60
HP:0000147HP:0008675Enlarged polycystic ovaries1ESR1 CL E G H20993467ORPHA:785Estrogen resistance syndromeHP:0040281 - Very frequent13
HP:0000147HP:0008675Enlarged polycystic ovaries1FSHR CL E G H24923969ORPHA:64739Ovarian hyperstimulation syndromeHP:0040281 - Very frequent50
HP:0000147HP:0008675Enlarged polycystic ovaries1KLLN CL E G H10014474837212ORPHA:201Cowden syndromeHP:0040283 - Occasional1
HP:0000147HP:0008675Enlarged polycystic ovaries1PIK3CA CL E G H52908975ORPHA:201Cowden syndromeHP:0040283 - Occasional162
HP:0000147HP:0008675Enlarged polycystic ovaries1POR CL E G H54479208ORPHA:95699Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiencyHP:0040283 - Occasional76
HP:0000147HP:0008675Enlarged polycystic ovaries1PTEN CL E G H57289588ORPHA:201Cowden syndromeHP:0040283 - Occasional948
HP:0000147HP:0008675Enlarged polycystic ovaries1PTEN CL E G H57289588ORPHA:744Proteus syndromeHP:0040283 - Occasional948
HP:0000147HP:0008675Enlarged polycystic ovaries1SDHB CL E G H639010681ORPHA:201Cowden syndromeHP:0040283 - Occasional237
HP:0000147HP:0008675Enlarged polycystic ovaries1SDHC CL E G H639110682ORPHA:201Cowden syndromeHP:0040283 - Occasional147
HP:0000147HP:0008675Enlarged polycystic ovaries1SDHD CL E G H639210683ORPHA:201Cowden syndromeHP:0040283 - Occasional129
HP:0000147HP:0008675Enlarged polycystic ovaries1SEC23B CL E G H1048310702ORPHA:201Cowden syndromeHP:0040283 - Occasional60
HP:0000147HP:0008675Enlarged polycystic ovaries1STK11 CL E G H679411389ORPHA:2869Peutz-Jeghers syndromeHP:0040283 - Occasional740
HP:0000147HP:0008675Enlarged polycystic ovaries1USF3 CL E G H20571730494ORPHA:201Cowden syndromeHP:0040283 - Occasional1


Genes (77) :AGPAT2 AKT1 AKT2 ALMS1 ANTXR2 ATM BAZ1B BCL7B BSCL2 BUD23 CAV1 CAVIN1 CBX2 CIDEC CLIP2 CORIN CYB5A CYP11B1 CYP17A1 CYP19A1 CYTB DHH DHX37 DMRT1 DNAJC30 EIF4H ELN ESR1 FKBP6 FLT1 FOS FOXL2 FSHR GTF2I GTF2IRD1 GTF2IRD2 HNF1A KLLN LIMK1 LIPE LMNA LMNB2 MAP3K1 METTL27 MLXIPL MMP14 MMP2 MSX1 NCF1 NR0B1 NR5A1 PHKA2 PHKB PHKG2 PIK3CA PLIN1 POR PPARG PTEN RFC2 SDHB SDHC SDHD SEC23B SETD2 SLC37A4 SOX3 SOX9 SRY STK11 STOX1 STX1A TBL2 TMEM270 USF3 VPS37D WT1

Diseases (43) :ORPHA:528 OMIM:608594 ORPHA:201 ORPHA:744 ORPHA:79085 ORPHA:64 ORPHA:2176 ORPHA:100 ORPHA:904 OMIM:269700 ORPHA:242 ORPHA:435651 ORPHA:275555 ORPHA:90796 ORPHA:90795 ORPHA:91 ORPHA:137675 ORPHA:785 ORPHA:572333 ORPHA:64739 OMIM:142330 ORPHA:435660 ORPHA:280365 ORPHA:2229 ORPHA:2348 ORPHA:79084 OMIM:151660 OMIM:608709 ORPHA:371428 ORPHA:2228 ORPHA:393 ORPHA:2138 ORPHA:264580 ORPHA:79240 ORPHA:280356 OMIM:201750 ORPHA:95699 OMIM:604367 ORPHA:79083 ORPHA:2969 OMIM:616831 ORPHA:79259 ORPHA:2869
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.